Skip to main content
logo
Genome & Company (KOSDAQ:314130)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,615.00
-45.00 (-1.69%)
At close: Aug 8, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Service
7.86B
Log In
Log In
Log In
Log In
Upgrade
Service Growth
6.06%
Log In
Log In
Log In
Log In
Upgrade
Immuno-cancer Drugs - Product
6.21B
Log In
Log In
Log In
Log In
Upgrade
Immuno-cancer Drugs - Product Growth
-3.87%
Log In
Log In
Log In
Log In
Upgrade
Usage Fee
211.93M
Log In
Log In
Log In
Log In
Upgrade
Usage Fee Growth
-0.13%
Log In
Log In
Log In
Log In
Upgrade
Immuno-cancer Drugs - Merchandise
15.50M
Log In
Log In
Log In
Log In
Upgrade
Immuno-cancer Drugs - Merchandise Growth
496.15%
Log In
Log In
Log In
Log In
Upgrade
Biological Products
-
Log In
Log In
Log In
Log In
Upgrade
Biological Products Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
South Korea
14.30B
Log In
Log In
Log In
Log In
Upgrade
South Korea Growth
1.50%
Log In
Log In
Log In
Log In
Upgrade